Using Medication Therapy Management to Optimize Medication Regimens, Identify Opioid Misuse

July 11, 2018

Medication therapy management serves as a channel of communication between pharmacists and patients, allowing pharmcists to optimize medication regimens for their patients and allowing patients to play an active role in their healthcare.

Providing an open channel of communication between pharmacists and patients, medication therapy management (MTM) allows pharmacists to optimize medications for their patients and patients to take an active role in their healthcare. As MTM services help pharmacists better understand how different medications interact with each other, MTM has been recommended as a way to identify and prevent opioid misuse.

In an effort to provide greater incentive for Part D sponsors to use MTM programs, the Center for Medicare and Medicaid Innovation launched in January 2017 the 5-year Part D Enhanced Medication Therapy Management (eMTM) Model. The model is assessing whether incentives, such as payment and regulatory flexibilities, will result in enhancements in the MTM program, ultimately leading to improved patient outcomes and reduced costs.

In this podcast, we speak with Brian Litten, JD, chief strategic officer, Tabula Rasa HealthCare; and Calvin Knowlton, BScPharm, MDiv, PhD, chief executive officer and founder of Tabula Rasa HealthCare, to get more insight into MTM and the eMTM model.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Effects of an Integrated Medication Therapy Management Program in a Pioneer ACO

Impact of Telephonic Comprehensive Medication Reviews on Patient Outcomes

CMS Testing New Medication Therapy Management Program

Patient Safety-Focused Medication Therapy Management: Challenges Affecting Future Implementation

Read more about MTM: